• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNMT3B通过微小RNA-152-3p/NCAM1途径调节A549细胞的增殖。

DNMT3B regulates proliferation of A549 cells through the microRNA-152-3p/NCAM1 pathway.

作者信息

Yang Bo, Huang Shiqing, Chen Hongming, Li Rizhu, Hou Shihao, Zhao Jingjing, Li Yepeng

机构信息

Department of Oncology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Zhuang Autonomous Region 533000, P.R. China.

Department of Cardiothoracic Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Zhuang Autonomous Region 533000, P.R. China.

出版信息

Oncol Lett. 2022 Jan;23(1):11. doi: 10.3892/ol.2021.13129. Epub 2021 Nov 10.

DOI:10.3892/ol.2021.13129
PMID:34820010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8607351/
Abstract

The purpose of the present study was to examine the epigenetic mechanism by which microRNA (miR)-152-3p regulates proliferation in non-small cell lung cancer A549 cells via neural cell adhesion molecule 1 (NCAM1). Bisulfite sequencing PCR (BSP), the gold standard for methylation detection, uses bisulfite-treated DNA to determine its pattern of methylation. Treatment of DNA with bisulfite converts cytosine residues to uracil, but leaves 5-methylcytosine residues unaffected. It was conducted and demonstrated a relatively high level of methylation in the miR-152-3p promoter region. Chromatin immunoprecipitation was combined with PCR to detect the binding of DNA methyltransferase 3B (DNMT3B) protein to miR-152-3p, which tends to occur in the core region of the miR-152-3p gene in A549 cells. Luciferase assay identified NCAM1 as the target gene of miR-152-3p. MTT, colony formation and Transwell assays indicated that miR-152-3p could decrease cell proliferation and invasion and in addition to reducing the expression level of NCAM1. Overexpression of NCAM1 could attenuate the effect of miR-152-3p. DNMT3B knockdown decreased the proliferative ability of A549 cells and increased the expression of miR-152-3p, while decreased that of NCAM1. After treatment with miR-152-3p inhibitor, these effects were attenuated and the NCAM1 expression level was upregulated. The results indicated that miR-152-3p may suppress the proliferation of A549 cells by downregulating NCAM1. In addition, DNMT3B negatively regulated the expression of miR-152-3p via modulation of the methylation level in the miR-152-3p core region, thus mediating the proliferation of lung tumor cells.

摘要

本研究的目的是探讨微小RNA(miR)-152-3p通过神经细胞黏附分子1(NCAM1)调节非小细胞肺癌A549细胞增殖的表观遗传机制。亚硫酸氢盐测序PCR(BSP)是甲基化检测的金标准,它使用经亚硫酸氢盐处理的DNA来确定其甲基化模式。用亚硫酸氢盐处理DNA会将胞嘧啶残基转化为尿嘧啶,但5-甲基胞嘧啶残基不受影响。研究发现并证实miR-152-3p启动子区域存在相对较高水平的甲基化。染色质免疫沉淀结合PCR检测DNA甲基转移酶3B(DNMT3B)蛋白与miR-152-3p的结合,这种结合倾向于发生在A549细胞中miR-152-3p基因的核心区域。荧光素酶报告基因检测确定NCAM1是miR-152-3p的靶基因。MTT、集落形成和Transwell实验表明,miR-152-3p可降低细胞增殖和侵袭能力,同时降低NCAM1的表达水平。NCAM1的过表达可减弱miR-152-3p的作用。敲低DNMT3B可降低A549细胞的增殖能力,增加miR-152-3p的表达,同时降低NCAM1的表达。用miR-152-3p抑制剂处理后,这些作用减弱,NCAM1表达水平上调。结果表明,miR-152-3p可能通过下调NCAM1抑制A549细胞的增殖。此外,DNMT通过调节miR-152-3p核心区域的甲基化水平对miR-152-3p的表达起负调控作用,从而介导肺肿瘤细胞的增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/51276a989060/ol-23-01-13129-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/0bc8fbbf2984/ol-23-01-13129-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/40b9a5729298/ol-23-01-13129-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/ddbf068f8a56/ol-23-01-13129-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/914707d5d717/ol-23-01-13129-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/4a12fa5fe6d6/ol-23-01-13129-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/51276a989060/ol-23-01-13129-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/0bc8fbbf2984/ol-23-01-13129-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/40b9a5729298/ol-23-01-13129-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/ddbf068f8a56/ol-23-01-13129-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/914707d5d717/ol-23-01-13129-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/4a12fa5fe6d6/ol-23-01-13129-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/8607351/51276a989060/ol-23-01-13129-g05.jpg

相似文献

1
DNMT3B regulates proliferation of A549 cells through the microRNA-152-3p/NCAM1 pathway.DNMT3B通过微小RNA-152-3p/NCAM1途径调节A549细胞的增殖。
Oncol Lett. 2022 Jan;23(1):11. doi: 10.3892/ol.2021.13129. Epub 2021 Nov 10.
2
MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.miR-124-3p 通过靶向 DNA 甲基转移酶 3B 抑制膀胱癌。
J Cell Physiol. 2018 Jan;234(1):464-474. doi: 10.1002/jcp.26591. Epub 2018 Jun 12.
3
Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4.微小RNA-324-3p的下调通过ALX4阻断NCAM1-MAPK轴来抑制肺癌。
Cancer Gene Ther. 2021 May;28(5):455-470. doi: 10.1038/s41417-020-00231-2. Epub 2020 Oct 21.
4
Upregulation of Neural Cell Adhesion Molecule 1 (NCAM1) by hsa-miR-141-3p Suppresses Ameloblastoma Cell Migration.hsa-miR-141-3p 通过上调神经细胞黏附分子 1(NCAM1)抑制造釉细胞瘤细胞迁移。
Med Sci Monit. 2020 Apr 9;26:e923491. doi: 10.12659/MSM.923491.
5
miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.miR-29c-3p 通过调控 DNMT3B 和 LATS1 的甲基化抑制肝癌的肿瘤进展。
Cell Death Dis. 2019 Jan 18;10(2):48. doi: 10.1038/s41419-018-1281-7.
6
MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.MicroRNA-486-3p 通过靶向 DDR1 发挥抑癌作用,抑制口腔癌的发生。
J Exp Clin Cancer Res. 2019 Jun 28;38(1):281. doi: 10.1186/s13046-019-1283-z.
7
Role of gga-miR-29b-3p in suppressing the proliferation, invasion and migration of MSB1 Marek's disease tumor cells by the targeting of the gene.gga-miR-29b-3p通过靶向该基因在抑制MSB1马立克氏病肿瘤细胞增殖、侵袭和迁移中的作用。
Ann Transl Med. 2022 Aug;10(16):873. doi: 10.21037/atm-22-3519.
8
Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.人参皂苷20(S)-Rg3通过调控DNMT3A/miR-532-3p/HK2通路抑制卵巢癌细胞的瓦伯格效应。
Cell Physiol Biochem. 2018;45(6):2548-2559. doi: 10.1159/000488273. Epub 2018 Mar 16.
9
MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.微小RNA-330-3p通过激活丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)信号通路,作用于谷氨酸受体离子otropic AMPA 3型(GRIA3),从而促进非小细胞肺癌的细胞侵袭和转移。
J Hematol Oncol. 2017 Jun 19;10(1):125. doi: 10.1186/s13045-017-0493-0.
10
microRNA-1236-3p Regulates DDP Resistance in Lung Cancer Cells.微小RNA-1236-3p调节肺癌细胞中的顺铂耐药性。
Open Med (Wars). 2019 Jan 16;14:41-51. doi: 10.1515/med-2019-0007. eCollection 2018.

引用本文的文献

1
Regulation and function of microRNA-152 in various types of cancers: its upstream regulators and downstream targets.微小RNA-152在各类癌症中的调控作用及其功能:其上游调控因子和下游靶点
Clin Exp Med. 2025 Jul 11;25(1):244. doi: 10.1007/s10238-025-01775-z.
2
Prion protein regulates invasiveness in glioblastoma stem cells.朊病毒蛋白调节胶质母细胞瘤干细胞的侵袭性。
BMC Cancer. 2024 Dec 18;24(1):1539. doi: 10.1186/s12885-024-13285-4.
3
DNMT1/miR-152-3p/SOS1 signaling axis promotes self-renewal and tumor growth of cancer stem-like cells derived from non-small cell lung cancer.

本文引用的文献

1
Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4.微小RNA-324-3p的下调通过ALX4阻断NCAM1-MAPK轴来抑制肺癌。
Cancer Gene Ther. 2021 May;28(5):455-470. doi: 10.1038/s41417-020-00231-2. Epub 2020 Oct 21.
2
A putative competing endogenous RNA network in cisplatin-resistant lung adenocarcinoma cells identifying potentially rewarding research targets.顺铂耐药肺腺癌细胞中的一个假定竞争性内源性RNA网络,可识别潜在有价值的研究靶点。
Oncol Lett. 2020 Jun;19(6):4040-4052. doi: 10.3892/ol.2020.11483. Epub 2020 Mar 27.
3
Suppressing microRNA-29c promotes biliary atresia-related fibrosis by targeting DNMT3A and DNMT3B.
DNMT1/miR-152-3p/SOS1 信号轴促进非小细胞肺癌来源的癌症干细胞样细胞的自我更新和肿瘤生长。
Clin Epigenetics. 2024 Apr 15;16(1):55. doi: 10.1186/s13148-024-01663-5.
4
Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance.非编码 RNA/DNMT3B 轴在人类癌症中的作用:从发病机制到临床意义。
J Transl Med. 2023 Sep 13;21(1):621. doi: 10.1186/s12967-023-04510-y.
5
ELF1 suppresses autophagy to reduce cisplatin resistance via the miR-152-3p/NCAM1/ERK axis in lung cancer cells.ELF1 通过 miR-152-3p/NCAM1/ERK 轴抑制自噬从而降低肺癌细胞对顺铂的耐药性。
Cancer Sci. 2023 Jun;114(6):2650-2663. doi: 10.1111/cas.15770. Epub 2023 Mar 20.
抑制 microRNA-29c 通过靶向 DNMT3A 和 DNMT3B 促进先天性胆道闭锁相关纤维化。
Cell Mol Biol Lett. 2019 Mar 11;24:10. doi: 10.1186/s11658-018-0134-9. eCollection 2019.
4
Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models.嵌合抗原受体 CD56-T 细胞在神经母细胞瘤和小细胞肺癌模型中的抗肿瘤活性。
Oncogene. 2018 Jul;37(27):3686-3697. doi: 10.1038/s41388-018-0187-2. Epub 2018 Apr 6.
5
The biology and management of non-small cell lung cancer.非小细胞肺癌的生物学特性与治疗管理。
Nature. 2018 Jan 24;553(7689):446-454. doi: 10.1038/nature25183.
6
miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.微小RNA-148a作为一种预后因素,通过Wnt1抑制非小细胞肺癌的迁移和侵袭。
PLoS One. 2017 Feb 15;12(2):e0171751. doi: 10.1371/journal.pone.0171751. eCollection 2017.
7
Expression of miR-148/152 family as potential biomarkers in non-small-cell lung cancer.miR-148/152家族作为非小细胞肺癌潜在生物标志物的表达
Med Sci Monit. 2015 Apr 23;21:1155-61. doi: 10.12659/MSM.892940.
8
Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: a case report.KRAS 突变型 NSCLC 中 RAF 抑制起始后的肿瘤 flares:一例报告。
Lung Cancer. 2015 Feb;87(2):201-3. doi: 10.1016/j.lungcan.2014.11.014. Epub 2014 Nov 29.
9
MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2.微小RNA-152通过抑制成纤维细胞生长因子2来抑制非小细胞肺癌细胞的增殖和侵袭。
Exp Mol Med. 2014 Sep 5;46(9):e112. doi: 10.1038/emm.2014.51.
10
MicroRNA-152 targets ADAM17 to suppress NSCLC progression.MicroRNA-152 靶向 ADAM17 抑制非小细胞肺癌进展。
FEBS Lett. 2014 May 21;588(10):1983-8. doi: 10.1016/j.febslet.2014.04.022. Epub 2014 Apr 26.